VINCERX PHARMA INC by Vincerx Pharma, Inc. Financials - Benzinga

VINCERX PHARMA INC by Vincerx Pharma, Inc.

VINCOTCEM

Trade with Public

Trade with Public

$0.1000

At close: May 8, 5:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare

VINCERX PHARMA INC by Vincerx Pharma, Inc. Financials

VINCERX PHARMA INC by Vincerx Pharma, Inc. (VINC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Vincerx Pharma Q1 EPS $(1.40) Up From $(11.60) YoY

Vincerx Pharma (NASDAQ:VINC) reported quarterly losses of $(1.40) per share. This is a 87.93 percent increase over losses of $(11.60) per share from the same period last year.

Benzinga Newsdesk

Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results

Avi Kapoor

PRO
Vincerx Pharma Q3 EPS $(0.17) Beats $(0.22) Estimate

Vincerx Pharma (NASDAQ:VINC) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.22) by 22.73 percent. This is a 59.52 percent increase over losses of $(0.42) per share from

Benzinga Newsdesk

PRO
Vincerx Pharma Q2 EPS $(0.05) Up From $(0.54) YoY

Benzinga Newsdesk

PRO
Vincerx Pharma Q1 EPS $(0.58) Misses $(0.29) Estimate

Vincerx Pharma (NASDAQ:VINC) reported quarterly losses of $(0.58) per share which missed the analyst consensus estimate of $(0.29) by 100 percent. This is a 14.71 percent increase over losses of $(0.68) per share from

Benzinga Newsdesk

Crude Oil Down Over 1%; Cognyte Software Shares Plummet

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0.46% to 38,713.72 while the NASDAQ fell 0.24% to 16,215.32. The S&P 500 also fell, dropping, 0.39% to 5,182.36.

Avi Kapoor